Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
175M
-
Number of holders
-
853
-
Total 13F shares, excl. options
-
99.6M
-
Shares change
-
+29.8M
-
Total reported value, excl. options
-
$19.9B
-
Value change
-
+$5.93B
-
Put/Call ratio
-
1.27
-
Number of buys
-
574
-
Number of sells
-
-228
-
Price
-
$199.96
Significant Holders of Teladoc Health, Inc. - Common Stock (TDOC) as of Q4 2020
994 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock as of Q4 2020.
Teladoc Health, Inc. - Common Stock (TDOC) has 853 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99.6M shares
of 175M outstanding shares and own 56.77% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (11.5M shares), ARK Investment Management LLC (7.83M shares), BAILLIE GIFFORD & CO (7.24M shares), JENNISON ASSOCIATES LLC (5.57M shares), Capital World Investors (4.24M shares), Sumitomo Mitsui Trust Holdings, Inc. (3.22M shares), Nikko Asset Management Americas, Inc. (2.82M shares), STATE STREET CORP (2.22M shares), BANK OF AMERICA CORP /DE/ (2.22M shares), and JPMORGAN CHASE & CO (2.17M shares).
This table shows the top 853 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.